As you probably know, RTOG needs to get funding from the NCI to conduct this trial.
In all seriousness, RTOG’s involvement is another bullish pointer. Although we can’t yet say that ADVS’ cancer vaccines work, there are several encouraging signs.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.